HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ebelactone B

esterase inhibitor; structure given in first source; see also ebelactone A
Also Known As:
2-ethyl-3,11-dihydroxy-4,6,8,10,12-pentamethyl-9-oxo-tetradecenoic 1,3-lactone; 2-Oxetanone, 3-ethyl-4-(8-hydroxy-1,3,5,7,9-pentamethyl-6-oxo-3-undecenyl)-, (3S-(3alpha,4beta(1R*,3E,5S*,7R*,8S*,9S*)))-
Networked: 12 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Majima, Masataka: 1 article (01/2014)
2. Katori, Makoto: 1 article (01/2014)
3. Horstick, Georg: 1 article (09/2012)
4. Schmidt, Thorsten: 1 article (09/2012)
5. Buning, Christian: 1 article (09/2012)
6. Kroll, Katja: 1 article (09/2012)
7. Linz, Wolfgang: 1 article (09/2012)
8. Ruf, Sven: 1 article (09/2012)
9. Hübschle, Thomas: 1 article (09/2012)
10. Linz, Dominik: 1 article (09/2012)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Thrombosis (Thrombus)
3. Obesity
4. Infection
5. Renovascular Hypertension (Goldblatt Syndrome)

Related Drugs and Biologics

1. Desoxycorticosterone (DOCA)
2. Cathepsin A
3. Exopeptidases (Exopeptidase)
4. Kinins
5. Tissue Kallikreins (Tissue Kallikrein)
6. Sodium
7. Phosphotransferases (Kinase)
8. Phenobarbital (Luminal)
9. Lipase (Acid Lipase)
10. Dietary Fats (Ghee)

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration